Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study.
OBJECTIVE
Most DTI studies in ALS have been limited to the assessment of the CST damage. In this study, we used DTI tractography to investigate whether microstructural abnormalities occur in the major motor and extramotor WM tracts in mildly disabled patients with ALS.


METHODS
Brain conventional MR imaging and DTI were performed in 24 patients with probable or definite ALS and mild disability (ALSFRS score, ≥20) and 20 healthy controls. The mean disease progression rate was 0.62 (range = 0.08-2.50). DTI tractography was used to segment the CST, the corpus callosum, and the major WM association tracts (ie, cingulum, uncinate fasciculus, inferior fronto-occipital, inferior longitudinal, and superior longitudinal fasciculi).


RESULTS
Compared with healthy controls, patients with ALS showed significantly decreased FA and significantly increased MD and radial D of the CST bilaterally (P values from .005 to .01). Patients with ALS also had a significantly increased axial D of the right uncinate fasciculus relative to controls (P = .04). CST FA significantly correlated with the rate of disease progression (right CST: r = -0.50, P = .02; left CST: r = -0.41, P = .05).


CONCLUSIONS
Patients with ALS and mild disability have preferential damage to the CST. The association of CST damage with the rate of disease progression suggests that DTI has the potential to provide in vivo markers of ALS evolution. The subtle involvement of the uncinate fasciculus may precede the appearance of behavioral symptoms in patients with ALS.
Agosta
F
F
Institute of Experimental Neurology, Scientific Institute and University Ospedale San Raffaele, Milan, Italy.
Pagani
E
E
Petrolini
M
M
Caputo
D
D
Perini
M
M
Prelle
A
A
Salvi
F
F
Filippi
M
M
D000328:Adult; D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000378:metabolism / Q000473:pathology*; D003337:Corpus Callosum / Q000378:metabolism / Q000473:pathology*; D056324:Diffusion Tensor Imaging; D004185:Disability Evaluation; D018450:Disease Progression; D004525:Efferent Pathways / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006801:Humans; D056784:Leukoencephalopathies / Q000378:metabolism / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index
Neuroradiology. 2008 Jul;50(7):605-11
18379765
Brain. 2010 Feb;133(Pt 2):529-39
19914928
J Neuroimaging. 2008 Jul;18(3):282-7
18808655
J Neurol Sci. 2002 Jul 15;199(1-2):59-65
12084444
Philos Trans R Soc Lond B Biol Sci. 2001 Aug 29;356(1412):1293-322
11545704
Magn Reson Med. 2000 Oct;44(4):625-32
11025519
Hum Brain Mapp. 2007 Dec;28(12):1430-8
17370339
Neurology. 2005 Jul 12;65(1):75-80
16009889
Ann Neurol. 1993 Feb;33(2):218-22
8434885
Brain. 2004 Feb;127(Pt 2):340-50
14607785
Radiology. 2005 Oct;237(1):258-64
16183935
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1250-7
12933929
Radiology. 1995 Jan;194(1):263-70
7997565
J Neurol Sci. 1994 Jul;124 Suppl:96-107
7807156
Amyotroph Lateral Scler. 2009 Oct-Dec;10(5-6):288-94
19922115
Adv Neurol. 1982;36:61-74
7180695
AJNR Am J Neuroradiol. 2007 Apr;28(4):724-30
17416829
J Neuroimaging. 1997 Oct;7(4):208-12
9344001
Neurology. 2007 Apr 24;68(17):1402-10
17452585
Hum Brain Mapp. 2010 Dec;31(12):1862-75
20162601
Neurology. 2004 Dec 14;63(11):2111-9
15596758
Ann Neurol. 1988 Apr;23(4):418-20
3382182
J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):53-5
18931009
N Engl J Med. 2001 May 31;344(22):1688-700
11386269
Neurology. 2003 Apr 8;60(7):1094-7
12682312
J Magn Reson B. 1996 Jun;111(3):209-19
8661285
Neurology. 2001 Aug 28;57(4):651-7
11524474
Radiology. 1989 Aug;172(2):535-9
2748836
NMR Biomed. 2004 Oct;17(6):411-6
15386625
J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):314-7
8795607
J Neurol Sci. 2004 Dec 15;227(1):73-8
15546594
IEEE Trans Med Imaging. 2003 Nov;22(11):1470-9
14606680
Hum Brain Mapp. 2009 Feb;30(2):615-24
18172851
J Magn Reson B. 1994 Mar;103(3):247-54
8019776
J Magn Reson Imaging. 2003 Oct;18(4):420-6
14508778
Cortex. 2008 Sep;44(8):1105-32
18619589
Neurology. 1999 Sep 22;53(5):1051-8
10496265
Neuroimage. 2008 Jul 1;41(3):657-67
18442927
Radiology. 2006 Jun;239(3):831-8
16641339
Neurology. 2008 Feb 12;70(7):528-32
18268244
Neuroimage. 2005 May 15;26(1):258-65
15862226
J Neurol Sci. 2001 May 1;186(1-2):37-44
11412870
Brain. 2006 Jul;129(Pt 7):1859-71
16672290
Radiology. 1996 Dec;201(3):637-48
8939209
Lancet Neurol. 2009 Jan;8(1):94-109
19081518
Lancet Neurol. 2007 Nov;6(11):994-1003
17945153
Arch Neurol. 2007 Feb;64(2):246-51
17296841
Neuroimage. 2007 Jan 15;34(2):486-99
17097892
Neuroimage. 2001 Jun;13(6 Pt 1):1174-85
11352623
Radiat Med. 2005 May;23(3):195-9
15940067
J Neuropathol Exp Neurol. 2005 Aug;64(8):730-9
16106222
Arch Neurol. 1996 Feb;53(2):141-7
8639063
Brain. 2009 Sep;132(Pt 9):2579-92
19439421
Med Phys. 1997 Jan;24(1):25-35
9029539
Science. 2006 Oct 6;314(5796):130-3
17023659
Neuroimage. 2010 Feb 1;49(3):2104-12
19782758
NMR Biomed. 2002 Nov-Dec;15(7-8):435-55
12489094